Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics Q2 EPS $(0.25)

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

byBenzinga Newsdesk

August 11, 2022

1 minute read

Context Therapeutics (NASDAQ:CNTX) reported quarterly losses of $(0.25) per share.

Why SentinelOne Shares Are Moving Higher After The Close

By Adam Eckert

August 31, 5:35 PM

SentinelOne, Inc (NYSE: S) shares are trading higher in Thursday's after-hours session on the heels of the cloud-based cybersecurity company's second-quarter resul

EVgo Secures $6.6M Public Funding To Deploy More Than 100 New DC Fast Charging Stalls

By Shivani Kumaresan

April 4, 7:54 AM

EVgo Inc (NASDAQ:EVGO) has bagged proposed awards of $6.6 million from the California Energy Commission’s (CEC) California Electric Vehicle Infrastructure Project…

EVGO

Louisiana-Pacific Shares Drop After Clocking 16% Sales Decline In Q4

By Anusuya Lahiri

February 21, 9:43 AM

Louisiana-Pacific Corp (NYSE: LPX) reported a fourth-quarter FY22 sales decline of 16% year-on-year to $705 million,

LPX

Movers
News

Dell Technologies Stock Rallied On Wednesday: What Happened?

By Vaishali Prayag

May 29, 5:01 PM

Dell Technologies (NYSE: DELL) shares experienced an uptick in trading activity on Wednesday following an upward price target revision from BofA Securities. Analyst Wamsi Mohan reaffirmed a Buy rating for Dell Technologies while lifting the price target from $130 to $180.

DELL

Context Therapeutics Q2 EPS $(0.25)

Related Posts

Why SentinelOne Shares Are Moving Higher After The Close

EVgo Secures $6.6M Public Funding To Deploy More Than 100 New DC Fast Charging Stalls

Louisiana-Pacific Shares Drop After Clocking 16% Sales Decline In Q4

Dell Technologies Stock Rallied On Wednesday: What Happened?